BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 38579174)

  • 21. Landscape of Microsatellite Instability Across 39 Cancer Types.
    Bonneville R; Krook MA; Kautto EA; Miya J; Wing MR; Chen HZ; Reeser JW; Yu L; Roychowdhury S
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 29850653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSCALite: a web server for gene set cancer analysis.
    Liu CJ; Hu FF; Xia MX; Han L; Zhang Q; Guo AY
    Bioinformatics; 2018 Nov; 34(21):3771-3772. PubMed ID: 29790900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarkers for Homologous Recombination Deficiency in Cancer.
    Hoppe MM; Sundar R; Tan DSP; Jeyasekharan AD
    J Natl Cancer Inst; 2018 Jul; 110(7):704-713. PubMed ID: 29788099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement and the Regulation of T Cell Responses.
    West EE; Kolev M; Kemper C
    Annu Rev Immunol; 2018 Apr; 36():309-338. PubMed ID: 29677470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Immune Landscape of Cancer.
    Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang TH; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA; Ziv E; Culhane AC; Paull EO; Sivakumar IKA; Gentles AJ; Malhotra R; Farshidfar F; Colaprico A; Parker JS; Mose LE; Vo NS; Liu J; Liu Y; Rader J; Dhankani V; Reynolds SM; Bowlby R; Califano A; Cherniack AD; Anastassiou D; Bedognetti D; Mokrab Y; Newman AM; Rao A; Chen K; Krasnitz A; Hu H; Malta TM; Noushmehr H; Pedamallu CS; Bullman S; Ojesina AI; Lamb A; Zhou W; Shen H; Choueiri TK; Weinstein JN; Guinney J; Saltz J; Holt RA; Rabkin CS; ; Lazar AJ; Serody JS; Demicco EG; Disis ML; Vincent BG; Shmulevich I
    Immunity; 2018 Apr; 48(4):812-830.e14. PubMed ID: 29628290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
    Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV; Omberg L; Wolf DM; Shriver CD; Thorsson V; ; Hu H
    Cell; 2018 Apr; 173(2):400-416.e11. PubMed ID: 29625055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.
    Racle J; de Jonge K; Baumgaertner P; Speiser DE; Gfeller D
    Elife; 2017 Nov; 6():. PubMed ID: 29130882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
    Li T; Fan J; Wang B; Traugh N; Chen Q; Liu JS; Li B; Liu XS
    Cancer Res; 2017 Nov; 77(21):e108-e110. PubMed ID: 29092952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.
    Nagarsheth N; Wicha MS; Zou W
    Nat Rev Immunol; 2017 Sep; 17(9):559-572. PubMed ID: 28555670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of complement inhibitors beyond controlling inflammation.
    Blom AM
    J Intern Med; 2017 Aug; 282(2):116-128. PubMed ID: 28345259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.
    Becht E; Giraldo NA; Lacroix L; Buttard B; Elarouci N; Petitprez F; Selves J; Laurent-Puig P; Sautès-Fridman C; Fridman WH; de Reyniès A
    Genome Biol; 2016 Oct; 17(1):218. PubMed ID: 27765066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Landscape of Pharmacogenomic Interactions in Cancer.
    Iorio F; Knijnenburg TA; Vis DJ; Bignell GR; Menden MP; Schubert M; Aben N; Gonçalves E; Barthorpe S; Lightfoot H; Cokelaer T; Greninger P; van Dyk E; Chang H; de Silva H; Heyn H; Deng X; Egan RK; Liu Q; Mironenko T; Mitropoulos X; Richardson L; Wang J; Zhang T; Moran S; Sayols S; Soleimani M; Tamborero D; Lopez-Bigas N; Ross-Macdonald P; Esteller M; Gray NS; Haber DA; Stratton MR; Benes CH; Wessels LFA; Saez-Rodriguez J; McDermott U; Garnett MJ
    Cell; 2016 Jul; 166(3):740-754. PubMed ID: 27397505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells.
    King BC; Esguerra JL; Golec E; Eliasson L; Kemper C; Blom AM
    J Immunol; 2016 Feb; 196(4):1636-45. PubMed ID: 26746193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlating chemical sensitivity and basal gene expression reveals mechanism of action.
    Rees MG; Seashore-Ludlow B; Cheah JH; Adams DJ; Price EV; Gill S; Javaid S; Coletti ME; Jones VL; Bodycombe NE; Soule CK; Alexander B; Li A; Montgomery P; Kotz JD; Hon CS; Munoz B; Liefeld T; Dančík V; Haber DA; Clish CB; Bittker JA; Palmer M; Wagner BK; Clemons PA; Shamji AF; Schreiber SL
    Nat Chem Biol; 2016 Feb; 12(2):109-16. PubMed ID: 26656090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.
    Seashore-Ludlow B; Rees MG; Cheah JH; Cokol M; Price EV; Coletti ME; Jones V; Bodycombe NE; Soule CK; Gould J; Alexander B; Li A; Montgomery P; Wawer MJ; Kuru N; Kotz JD; Hon CS; Munoz B; Liefeld T; Dančík V; Bittker JA; Palmer M; Bradner JE; Shamji AF; Clemons PA; Schreiber SL
    Cancer Discov; 2015 Nov; 5(11):1210-23. PubMed ID: 26482930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.
    Englund E; Reitsma B; King BC; Escudero-Esparza A; Owen S; Orimo A; Okroj M; Anagnostaki L; Jiang WG; Jirström K; Blom AM
    BMC Cancer; 2015 Oct; 15():737. PubMed ID: 26480818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation.
    Liszewski MK; Kolev M; Le Friec G; Leung M; Bertram PG; Fara AF; Subias M; Pickering MC; Drouet C; Meri S; Arstila TP; Pekkarinen PT; Ma M; Cope A; Reinheckel T; Rodriguez de Cordoba S; Afzali B; Atkinson JP; Kemper C
    Immunity; 2013 Dec; 39(6):1143-57. PubMed ID: 24315997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of complement activation and regulation.
    Noris M; Remuzzi G
    Semin Nephrol; 2013 Nov; 33(6):479-92. PubMed ID: 24161035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferring tumour purity and stromal and immune cell admixture from expression data.
    Yoshihara K; Shahmoradgoli M; Martínez E; Vegesna R; Kim H; Torres-Garcia W; Treviño V; Shen H; Laird PW; Levine DA; Carter SL; Getz G; Stemke-Hale K; Mills GB; Verhaak RG
    Nat Commun; 2013; 4():2612. PubMed ID: 24113773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules.
    Basu A; Bodycombe NE; Cheah JH; Price EV; Liu K; Schaefer GI; Ebright RY; Stewart ML; Ito D; Wang S; Bracha AL; Liefeld T; Wawer M; Gilbert JC; Wilson AJ; Stransky N; Kryukov GV; Dancik V; Barretina J; Garraway LA; Hon CS; Munoz B; Bittker JA; Stockwell BR; Khabele D; Stern AM; Clemons PA; Shamji AF; Schreiber SL
    Cell; 2013 Aug; 154(5):1151-1161. PubMed ID: 23993102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.